Original Research
Accepted on 29 Jul 2024
High socioeconomic impact on prescription behavior despite unrestricted access to disease-modifying therapies in people with multiple sclerosis
in Multiple Sclerosis and Neuroimmunology
Original Research
Accepted on 29 Jul 2024
in Multiple Sclerosis and Neuroimmunology
Original Research
Accepted on 29 Jul 2024
in Cardiovascular and Smooth Muscle Pharmacology
Original Research
Accepted on 29 Jul 2024
in Thoracic Oncology
Original Research
Accepted on 29 Jul 2024
in Neuroendocrine Science
Review
Accepted on 29 Jul 2024
in Inflammation
Brief Research Report
Accepted on 29 Jul 2024
in Multiple Sclerosis and Neuroimmunology
Original Research
Accepted on 29 Jul 2024
in Asthma
Case Report
Accepted on 29 Jul 2024
in Cancer Endocrinology
Original Research
Published on 29 Jul 2024
in Cancer Immunity and Immunotherapy
Original Research
Published on 29 Jul 2024
in Gynecological Oncology
Original Research
Published on 29 Jul 2024
in Geohazards and Georisks
Case Report
Published on 29 Jul 2024
in Head and Neck Cancer
Systematic Review
Published on 29 Jul 2024
in Science and Environmental Communication
Editorial
Published on 29 Jul 2024
in Surgical Oncology
Editorial
Published on 29 Jul 2024
in Cellular Endocrinology
Systematic Review
Published on 29 Jul 2024
in Gastrointestinal and Hepatic Pharmacology